Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure

ClinicalTrials.gov ID: NCT05165290

Public ClinicalTrials.gov record NCT05165290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Prospective, double-masked, randomized, multi-center, active-controlled, parallel-group, 3-month study assessing the safety and ocular hypotensive efficacy of TearClear latanoprost Ophthalmic Solution, 0.005% (TC-002) compared to latanoprost Ophthalmic Solution, 0.005% (LAT) in subjects with elevated intraocular pressure at approximately 20 study sites located in the United States

Study identification

NCT ID
NCT05165290
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
TearClear Corp
Industry
Enrollment
300 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2021 (Actual)
Primary completion
Sep 2022 (Estimated)
Completion
Sep 2022 (Estimated)
Last update posted
May 25, 2022

2021 – 2022

United States locations

U.S. sites
20
U.S. states
8
U.S. cities
19
Facility City State ZIP Site status
Orange County Ophthalmology Medical Group Garden Grove California 92843 —
Global Research Management Glendale California 91204 —
North Valley Eye Medical Group Mission Hills California 91345 —
Eye Research Foundation Newport Beach California 92663 —
North Bay Eye Associates Petaluma California 94954 —
Martel Eye Medical Group Rancho Cordova California 95670 —
Wolstan & Goldberg Eye Associates Torrance California 90505 —
Michael K. Tran, MD Westminster California 92683 —
Segal Drug Trials Delray Beach Florida 33484 —
Shettle Eye Research Inc. Largo Florida 33773 —
International Research Center Tampa Florida 33603 —
The Eyecare Institute/Butcherton Clinical Trials Louisville Kentucky 40206 —
Rochester Ophthalmological Group PA Rochester New York 14618 —
Abrams Eye Center Cleveland Ohio 44115 —
Scott & Christie Associates PC Cranberry Township Pennsylvania 16066 —
Total Eye Care P.A. Memphis Tennessee 38119 —
Louis M. Alpern, M.D., M.P.H., P.A. El Paso Texas 79902 —
Houston Eye Associates Houston Texas 77008 —
R&R Research LLC San Antonio Texas 78229 —
San Antonio Eye Center San Antonio Texas 78238 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05165290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 25, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05165290 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →